×
Seguir
Highlight

BioHope

Startup

diagnostic and therapeutic solutions for the immunological clinical management of kidney transplanted patients

SECTORES

WEB OFICIAL

About BioHope

Biohope products cover two unmet clinical needs: a) 50% of transplanted kidneys are lost during the first 10 years because of chronic rejection in spite of using immunosuppresor treatment for their entire life; b) 1/3 of transplanted patients die because of complications derived of the induced immunosuppression to prevent rejection. Biohope is currently developing two products: 1) DIAGNOSTIC SOFTWARE for: a) The early identification of patients at risk of chronic rejection, enabling the clinicians to make early decisions on therapy adjustment to avoid graft rejection b) The early identification of patients under feasible immunosuppression reduction, enabling a gradual reduction and even withdrawal of immunosuppression 2) COMPANION DIAGNOSTICS bioassay to support clinicians in the determination of the optimal combination/posology of immunosuppressant drugs Biohope products have also potential application to other immune-based diseases like reumatoid arthritis, lupus and other

Image Gallery BioHope 3

Images from BioHope Images from BioHope Images from BioHope

Data BioHope

Offices
Locations

Equipo BioHope 1

Inversores BioHope 0

BioHope no tiene a su equipo agregado

Acceleradoras BioHope 1

Noticias BioHope 0

BioHope no tiene ninguna noticia disponible.

Cookies policy We use proprietary and third-party cookies to improve our services and user experience. If you continue to browse, we believe you accept its use.

Accept